Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Technical420.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.
The nature of cannabis industry has changed a lot in a short period of time and this leaves a lot of questions for investors. Earlier this month, Tilray made headlines after the Canadian cannabis producer surged higher and traded as high as $300, writes Michael Berger.
Cannabis stock expert Michael Berger, president of Technical420.com, highlights one of the highest-quality licensed medical cannabis producers in Canada that is raising capital before its 2017 planned initial public offering.
For investors looking for a growth stock that is disrupting a multi-billion-dollar market, market expert Michael Berger — President of Technical420 — highlights a Canadian-based development-stage healthcare technology company that is very undervalued and has remarkable growth potential.
For investors looking for a high-growth stock operating in the fastest growing industry in the world, cannabis market expert Michael Berger - President of Technical420 - highlights a Canadian-based development-stage company that is very undervalued and has remarkable growth potential.
Canada has been at the center of the cannabis expansion, which is taking place on a global scale. The opening of the recreational cannabis market has created significant opportunities for companies. This panel features leading Canadian cannabis companies and this is a discussion that investors need to attend.
In 2018, the United States cannabis industry recorded significant growth and this is a trend that we expect to continue for years to come. This panel features leading expects focused on all facets of the United stated cannabis industry. The recent pullback has created a great opportunity for new investors and this is a discussion that cannot be missed.
From biotech to edibles, consulting to technology, the legal cannabis industry offers U.S. investors significant investment opportunities. this panel of experts features executives from cannabis companies that are capitalizing on the United States cannabis industry and will discuss some of the way investors can capitalize on the burgeoning cannabis sector.